Literature DB >> 15085913

Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD).

F Godemann1, C Butter, F Lampe, M Linden, S Werner, S Behrens.   

Abstract

OBJECTIVES: In high-risk cardiac patients the treatment of life-threatening arrhythmias with an implantable cardioverter/defibrillator (ICD) extends survival. Other important outcome criteria are treatment side effects especially the quality of life (QoL). Knowledge of the variables that influence QoL is important for therapy decisions in ICD patients.
METHODS: Ninety-three ICD patients evaluated their QoL by the SF-36 after 1-6 years of ICD implantation. The QoL was studied in relation to cardiac function (severity of heart failure, ejection fraction), treatment course (number of shocks), coping styles and psychiatric syndromes.
RESULTS: About 30% of the somatic QoL (physical role function, pain) is determined by the patients' somatization tendency, i.e. the extent to which they suffer from non-specific symptoms (sweating, weakness in the legs, nausea). The severity of heart failure had little influence on the physical QoL. The emotional QoL is primarily determined by phobic anxiety of ICD patients.
CONCLUSIONS: Psychiatric symptoms are the most important factors to determine the QoL in ICD patients. Behavioural treatment procedures of phobic anxieties and somatization could improve QoL in ICD patients.

Entities:  

Mesh:

Year:  2004        PMID: 15085913     DOI: 10.1023/B:QURE.0000018493.32844.56

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  20 in total

Review 1.  Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials.

Authors:  K Kroenke; R Swindle
Journal:  Psychother Psychosom       Date:  2000 Jul-Aug       Impact factor: 17.659

2.  Cognitive-behavioral treatment of panic disorder with agoraphobia triggered by AICD implant activity.

Authors:  L C Smith; D Fogel; S Friedman
Journal:  Psychosomatics       Date:  1998 Sep-Oct       Impact factor: 2.386

3.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

4.  Classic conditioning and dysfunctional cognitions in patients with panic disorder and agoraphobia treated with an implantable cardioverter/defibrillator.

Authors:  F Godemann; B Ahrens; S Behrens; R Berthold; C Gandor; F Lampe; M Linden
Journal:  Psychosom Med       Date:  2001 Mar-Apr       Impact factor: 4.312

5.  Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial.

Authors:  P B Namerow; B R Firth; G M Heywood; J R Windle; M K Parides
Journal:  Pacing Clin Electrophysiol       Date:  1999-09       Impact factor: 1.976

6.  Impact of cognitive-behavioral treatment on quality of life in panic disorder patients.

Authors:  M J Telch; N B Schmidt; T L Jaimez; K M Jacquin; P J Harrington
Journal:  J Consult Clin Psychol       Date:  1995-10

7.  A comparison of cognitive and guided mastery therapy of agoraphobia.

Authors:  A Hoffart
Journal:  Behav Res Ther       Date:  1995-05

8.  Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure.

Authors:  D Böcker; D Bänsch; A Heinecke; M Weber; J Brunn; D Hammel; M Borggrefe; G Breithardt; M Block
Journal:  Circulation       Date:  1998-10-20       Impact factor: 29.690

9.  Predictors of psychosocial adjustment in patients with implantable cardioverter defibrillators.

Authors:  E S Burgess; J F Quigley; G Moran; F J Sutton; M Goodman
Journal:  Pacing Clin Electrophysiol       Date:  1997-07       Impact factor: 1.976

10.  Somatization and medicalization in the era of managed care.

Authors:  A J Barsky; J F Borus
Journal:  JAMA       Date:  1995-12-27       Impact factor: 56.272

View more
  15 in total

1.  Phantom shocks in implantable cardioverter-defibrillator recipients: impact of education level, anxiety, and depression.

Authors:  Swaroop Varghese; J Christoph Geller; Marc-Alexander Ohlow
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-08-22

Review 2.  Treatment of ventricular tachycardia in patients with heart failure.

Authors:  Michael W Fong; Luanda Grazette; David Cesario; Michael Cao; Leslie Saxon
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

3.  Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators.

Authors:  Jennifer L Francis; Ali A Weinstein; David S Krantz; Mark C Haigney; Phyllis K Stein; Peter H Stone; John S Gottdiener; Willem J Kop
Journal:  Psychosom Med       Date:  2009-08-06       Impact factor: 4.312

4.  Preliminary Development of an Informational Media Use Measure for Patients with Implanted Defibrillators: Toward a Model of Social-Ecological Assessment of Patient Education and Support.

Authors:  Christopher E Knoepke; Daniel D Matlock
Journal:  Health Soc Work       Date:  2017-11-01

5.  Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators.

Authors:  Chi-Wen Kao; Erika Friedmann; Sue A Thomas
Journal:  Qual Life Res       Date:  2010-02-03       Impact factor: 4.147

6.  Reduction in Ventricular Tachyarrhythmia Burden in Patients Enrolled in the RAID Trial.

Authors:  Arwa Younis; Ilan Goldenberg; Shamroz Farooq; Hagai Yavin; James Daubert; Merritt Raitt; Alexander Mazur; David T Huang; Brent L Mitchell; Mayer R Rashtian; Stephen Winters; Margot Vloka; Mehmet Aktas; Matthew A Bernabei; Christopher A Beck; Scott McNitt; Wojciech Zareba
Journal:  JACC Clin Electrophysiol       Date:  2022-04-27

7.  Cognitive and behavioral treatments for anxiety and depression in a patient with an implantable cardioverter defibrillator (ICD): a case report and clinical discussion.

Authors:  Adam T Hirsh; Samuel F Sears; Jamie B Conti
Journal:  J Clin Psychol Med Settings       Date:  2009-04-30

8.  Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy.

Authors:  Christian Knackstedt; Marlies Arndt; Karl Mischke; Nikolaus Marx; Fred Nieman; Hanns Jürgen Kunert; Patrick Schauerte; Christine Norra
Journal:  Heart Vessels       Date:  2013-06-04       Impact factor: 2.037

9.  Psychiatric disorders and quality of life in patients with implantable cardioverter defibrillators: a systematic review.

Authors:  Ana Claudia C de Ornelas Maia; Gastão Soares-Filho; Valeska Pereira; Antonio Egidio Nardi; Adriana Cardoso Silva
Journal:  Prim Care Companion CNS Disord       Date:  2013-04-18

10.  COPE-ICD: a randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population.

Authors:  Selina K Berg; Jesper H Svendsen; Ann-Dorthe Zwisler; Birthe D Pedersen; Pernille Preisler; Lone Siersbæk-Hansen; Mette B Hansen; Rune H Nielsen; Preben U Pedersen
Journal:  BMC Cardiovasc Disord       Date:  2011-06-17       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.